Ligand-gated ion channels participate in synaptic transmission, and they are involved in neurotransmitter release. The functions of the channels are regulated by a variety of modulators. The interaction of 2,2,2-trichloroethanol, the active hypnotic metabolite of chloral hydrate, with the 5-hydroxytryptamine (5-HT) (serotonin) type 3 receptor results in a positive allosteric modulation. We have demonstrated previously that arginine 246 (R246) located in the pretransmembrane domain 1 is critical for coupling agonist binding to gating. In this study, we examined the role of R246 in the action of trichloroethanol with a combination of mutagenesis and whole-cell patch-clamp techniques. The R246A mutation converted the partial agonist dopamine into a full agonist at the 5-HT 3A receptor, and it facilitated activation of the mutant receptor by dopamine, suggesting an enhanced gating process due to the mutation. The positive modulation of the 5-HT 3A receptor by trichloroethanol was dramatically reduced by the R246A mutation. Trichloroethanol had little agonist activity in the wild-type receptor (Ͻ1% of maximal 5-HT response). However, the R246A mutation significantly increased the direct activation of the receptor by trichloroethanol in the absence of agonist (ϳ10% of maximal 5-HT response). The current activated by trichloroethanol could be blocked by the competitive 5-HT 3 receptor antagonist tropanyl 3,5-dichlorobenzoate (MDL 72222), and it had a similar reversal potential to those of current activated by 5-HT. In addition, predesensitization of the mutant receptor by trichloroethanol prevented 5-HT from activating the receptor. These data suggest that R246 is a crucial site for mediating the actions of both agonists and modulators.
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The 5-hydroxytryptamine (5-HT) (serotonin) type 3 receptor is a member of the Cys-loop ligand-gated ion channel superfamily that also includes the nicotinic acetylcholine, GABA A , and glycine receptors (Karlin, 2002) . Members of the Cys-loop ligand-gated ion channel superfamily are pentameric assemblies, with each subunit composed of four transmembrane domains, a large extracellular N terminus, a short extracellular C terminus, and loops connecting the transmembrane domains (TMs). It has been proposed that the agonist binding domains are formed by the extracellular N terminus at the interface between subunits, whereas the channel pore is lined by transmembrane domain 2 (Karlin, 2002) . The activation of the Cys-loop ligand-gated ion channels involves the binding of the agonist to the receptor, the transduction of the binding signal to the channel gate, and the opening of the channel. The structural determinants in portions of loops 2, 7, and 9 and ␤8-␤9 linker of the extracellular N terminus (Absalom et al., 2003; Lee and Sine, 2005; Xiu et al., 2005; Sine and Engel, 2006; Gay and Yakel, 2007) , preTM1 (Hu et al., 2003; Kash et al., 2003; Lee and Sine, 2005; Xiu et al., 2005; Keramidas et al., 2006; Mercado and Czajkowski, 2006) , and transmembrane domain 2-3 loop (Grosman et al., 2000; Kash et al., 2003; Lummis et al., 2005; Xiu et al., 2005) have been implicated in relaying agonist binding to channel gating. It is interesting to note that those elements in the transduction pathway are also critical for allosteric modulation (Mihic et al., 1997; Krasowski et al., 1998b; Boileau and Czajkowski, 1999; Carlson et al., 2000; Chang et al., 2003; Hu and Lovinger, 2005; Jones-Davis et al., 2005) .
5-HT 3 receptors are expressed in both the central and peripheral nervous systems, and they are thought to participate in a variety of physiological functions such as cognitive processing, sensory transmission, regulation of autonomic function, integration of the vomiting reflex, pain processing, and control of anxiety (Barnes and Sharp, 1999) . The 5-HT 3A subunit was first cloned in 1991 (Maricq et al., 1991) . Since then, an additional four subunits, 3B, 3C, 3D, and 3E, have been added to the 5-HT 3 receptor family (Davies et al., 1999; Niesler et al., 2003) . Only the 3A and 3B subunits have been investigated in detail, whereas the functional role of the 3C, 3D, and 3E is not clear at present. The homomeric assembly of the 3A subunits, but not the 3B subunits, can form functional channels. Coexpression of the 3A and 3B subunits leads to formation of a heteromeric receptor that displays different biophysical properties from the homomeric 5-HT 3A receptor (Davies et al., 1999; Dubin et al., 1999; Hapfelmeier et al., 2003) . The functions of the 5-HT 3 receptor can be tuned by allosteric modulators such as ions, alcohol, and anesthetics (Lovinger and Zhou, 1993; Hu and Lovinger, 2005) . Chloral hydrate is a widely used hypnotic and anesthetic agent; and trichloroethanol is the active metabolite of chloral hydrate and an analog of ethanol. Allosteric modulation of Cys-loop ligand-gated ion channels by trichloroethanol has been observed in the 5-HT 3 (Lovinger and Zhou, 1993) , GABA A (Krasowski et al., 1998a) , and glycine (Krasowski et al., 1998a) receptors. However, the critical elements in the Cys-loop ligand-gated ion channels for trichloroethanol action are not fully understood. There is a cluster of three positively charged arginine residues at the C-terminal end of the extracellular N terminus of the 5-HT 3A receptor (Fig. 1A) . The last arginine residue, R246, has been found to be one of the transducing elements in coupling agonist binding to channel gating (Hu et al., 2003) . The goal of this study was to investigate the role of R246 in the action of 2,2,2-trichloroethanol. Our results reveal that the R246 residue of the mouse 5-HT 3A receptor is a pivotal site for both coupling agonist binding to channel gating and mediating the action of trichloroethanol.
Materials and Methods
Mutagenesis. Point mutation of the mouse 5-HT 3A receptor isoform 1 (NP_038589; a gift from Dr. D. Julius, University of California, San Francisco, CA) was accomplished using the QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, CA). The successful incorporation of mutations was verified by sequencing the clones using an ABI Prism 377 automated DNA sequencer (Applied Biosystems, Foster City, CA). The cDNAs were then subcloned into the vector pCDNA3.1 (Invitrogen, Carlsbad, CA) for expression in human embryonic kidney (HEK) 293 cells.
Cell Culture and Transient Receptor Expression. HEK 293 cells (American Type Culture Collection, Manassas, VA) were grown in minimum essential medium (Invitrogen) supplemented with 10% horse serum, and they were maintained in a humidified incubator at 37°C in 5% CO 2 . HEK 293 cells were transiently transfected with the wild-type or mutant 5-HT 3A receptor cDNA using the Lipofectamine 2000 reagent (Invitrogen) according to the manufacturer's instructions. Green fluorescent protein (pGreen Lantern; Invitrogen) was coexpressed with the 5-HT 3A receptor subunits to permit selection of transfected cells under fluorescence optics. Each 35-mm dish was transfected with 3 g of cDNA encoding the wild-type or mutant receptors along with 1 g of green fluorescent protein cDNA.
Whole-Cell Patch-Clamp Recording. Whole-cell recordings were performed in HEK 293 cells 1 to 3 day after transfection. HEK 293 cells were replated on the day of the experiment to ensure that recordings were only made from single, isolated cells. Cells were continuously superfused with a solution containing 140 mM NaCl, 5 mM KCl, 1.8 mM CaCl 2 , 1.2 mM MgCl 2 , 5 mM glucose, and 10 mM HEPES (pH was adjusted to 7.4 with NaOH and osmolarity was adjusted to ϳ340 mOsmol with sucrose). Pipettes were pulled from borosilicate glass (TW-150F; WPI, Sarasota, FL) using a multistage puller (Flaming-Brown P-97; Sutter Instrument Company, Novato, CA), and they had resistances of 2 to 5 M⍀ when filled with pipette solution containing 140 mM CsCl, 2 mM MgCl 2 , 10 mM EGTA, 10 mM HEPES (pH was adjusted to 7.2 with CsOH, and osmolarity adjusted to ϳ315 mOsmol with sucrose). Membrane current was recorded in the whole-cell configuration using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA) at 20 to 22°C. Cells were held at Ϫ60 mV unless otherwise indicated. Data were acquired using pClamp 9.0 software (Molecular Devices). Currents were filtered at 2 kHz, and they were digitized at 5 to 10 kHz.
Agonists were applied with a piezoelectric device (PZ-150M; EXFO Burleigh Products Group Inc., Victor, NY) or a stepper motor-driven apparatus (Fast-Step; Warner Instruments, Hamden, CT) through a two-barrel theta glass tubing (TGC150; Warner Instruments, Hamden, CT) that had been pulled to a tip diameter of ϳ200 m. The cell was placed in front of the stream of control solution. The piezoelectric device or stepper motor-driven apparatus was driven by transistortransistor logic pulses from the pClamp 9.0 software (Molecular Devices), which produce a rapid lateral displacement (ϳ50 m) of the tubing to move the interface between control and agonist solutions. Solution exchange rate for open pipette and whole-cell recording was estimated using the potential change induced by switching from the control solution to a 140 mM N-methyl-D-glucamine test solution at 0 mV in the absence of agonist; and the current rising phase was fit using an exponential function. The solution exchange time constants were ϳ0.3 ms for an open pipette tip and ϳ1.6 ms for whole-cell recording.
Data Analysis. Data analysis and curve fitting were performed with Origin 7.0 (OriginLab Corp., Northampton, MA), pClamp 9.0 (Molecular Devices), or InStat 3.0 (GraphPad Software Inc., San Diego, CA) software. Concentration-response data for dopamine were fit using the Hill equation
nh ], where I is the current amplitude activated by a given concentration of agonist ([agonist]), I 30 M 5-HT is the current amplitude of the cell in response to 30 M 5-HT, n h is the Hill coefficient, and EC 50 is the concentration eliciting a half-maximal response.
Parameters of channel activation and deactivation and desensitization were estimated by fitting appropriate current components using exponential functions of the general form ⌺A n e (Ϫt/n ) ϩ A s , where A n is the relative amplitude of the respective component, A s is the steady-state current, n is the optimal number of exponential components, t is time, and n is the respective time constant. Curve fitting was achieved in Clampfit 9.0 using the Levenberg-Marquardt algorithm. Additional components were accepted only if they significantly improved the fit, as determined by an F-test performed using the analysis software.
Activation rates were derived from exponential fitting of the rising phase of agonist activated current. Desensitization time constants were derived from exponential fits to the current decay starting just after the current peak and extending to the end of agonist application. Deactivation time constants were derived from exponential fits to the current decay after the removal of agonist. To facilitate direct comparison of desensitization with single versus multiple components, a weighted summation of time constants (⌺a n n ) was used, where a n is the fractional contribution of the respective component, n is the respective time constant, and n is the optimal number of exponential components.
In some experiments, voltage ramps were applied to measure reversal potential and channel rectification. A ramp with a slew rate of 0.5 mV/ms was applied during the peak of current activated by 3 M 5-HT and 10 mM 2,2,2-trichloroethanol (trichloroethanol). Current activated by a voltage ramp in the absence of agonist was subtracted from the ramp-activated current in the presence of agonist before plotting and analyzing these data.
Data are presented as mean Ϯ S.E.M. Statistical significance was determined with the Student's t test or one-way analysis of variance. Differences were considered significant at p Ͻ 0.05.
Results

R246 Mutation Increases the Relative Efficacy of the Partial Agonist Dopamine.
Both the wild-type and R246 mutant receptors were transiently expressed in HEK 293 cells; and the effect of the R246 mutation on the current activated by dopamine, a 5-HT 3 receptor partial agonist, was examined with whole-cell patch-clamp recording. Representative responses activated by 5-HT and dopamine are shown in Fig. 1B . At maximally efficacious concentrations, 3 mM dopamine was less effective than 30 M 5-HT in activating the wild-type receptor, confirming the partial agonism of dopamine at the 5-HT 3 receptor. However, dopamine was as effective as 5-HT in activating the mutant receptor. Application of dopamine activated concentration-dependent responses in both the wild-type and mutant receptors (Fig. 1C) . The R246A mutation shifted the dopamine concentrationresponse curve to the left. The EC 50 for the mutant receptor (55.8 Ϯ 10.3 M) was smaller than that for the wild-type receptor (140.0 Ϯ 4.5 M), suggesting an increased agonist potency by the R246A mutation. The Hill coefficient for the wild-type and mutant receptor was 1.9 Ϯ 0.1 and 1.1 Ϯ 0.1, respectively. In addition, the R246A mutation increased the maximal response activated by dopamine from 29.8 Ϯ 1.4 to 91.6 Ϯ 1.4% of the response activated by 30 M 5-HT. Dopamine at 3 mM elicited a much faster-activating inward current in the mutant receptor than in the wild-type receptor (Fig. 1D) ; and the R246A mutation resulted in a ϳ25-fold increase in activation rate of the receptor in response to dopamine (Fig. 1E) .
R246A Mutation Essentially Eliminates Trichloroethanol Effect on Desensitization. Desensitization is a common feature of ligand-gated ion channels. As shown in Fig. 2A , 5-HT-activated current decayed during prolonged agonist application in the wild-type receptor, and coapplication of trichloroethanol with 5-HT slowed down the current decay. Consistent with previous findings (Hu et al., 2003) , desensitization was faster in the R246A mutant receptor than in the wild-type receptor ( Fig. 2A) . Coapplication of trichloroethanol and 5-HT seemed to slightly decrease desensitization in the mutant receptor. Desensitization time course was best fit with a monoexponential function in the wild-type receptor, and the rate of desensitization was ϳ4-fold slower in the presence of trichloroethanol (Fig. 2B) . However, desensitization in the mutant receptor, displayed a biexponential function. It seems that the R246A mutation largely abolished the trichloroethanol effect on receptor desensitization. For example, trichloroethanol did not alter the time constant for the fast component of desensitization, whereas it slightly slowed down the time constant for the slow component of desensitization (Fig. 2B) . In addition, trichloroethanol did not alter the proportion of the fast and slow 5) . Furthermore, the overall desensitization measured as the weighted desensitization time constant was not significantly altered by trichloroethanol in the R246A receptor (1.8 Ϯ 0.2 3 2.2 Ϯ 0.4 s; p Ͼ 0.08).
R246A Mutation Reduces Trichloroethanol Modulation of Dopamine Current. In addition to decreasing desensitization kinetics, alcohol has also been found to increase the peak current activated by dopamine and low concentrations of 5-HT at the 5-HT 3A receptor (Machu and Harris, 1994; Lovinger et al., 2000) . Therefore, modulation of the 5-HT 3A receptor by trichloroethanol was further examined using dopamine to activate the receptor. In addition, the effect of ethanol on dopamine-activated current was also studied based on the structural similarity between trichloroethanol and ethanol. In this set of experiments, three concentrations of dopamine (EC 35 , EC 65 , and EC 100 ) were used for both the wild-type and mutant receptors. The activation of the 5-HT 3A receptor by dopamine seemed much faster in the mutant receptor at each corresponding concentration. Coapplication of either trichloroethanol or ethanol with dopamine enhanced peak current in the wild-type receptor, and trichloroethanol seemed to be more potent than ethanol. The potentiation by both compounds was dopamine concentration-dependent, with greater enhancement seen at lower concentrations. However, the potentiation of dopamine-activated current by trichloroethanol and ethanol was less obvious in the mutant receptor (Fig. 3A) . Averaged data revealed that dopamine-activated current amplitude was enhanced by ϳ2100, 700, and 300% with trichloroethanol and by ϳ130, 70, and 60% with ethanol at EC 35 , EC 65 , and EC 100 of dopamine, respectively, in the wild-type receptor (Fig. 3B) . However, ethanol only enhanced dopamine-activated current amplitude by ϳ20% at EC 35 and EC 65 of dopamine; and it failed to potentiate EC 100 dopamine-activated current in the mutant receptor. Furthermore, the potentiation by trichloroethanol was dramatically reduced by the R246A mutation; trichloroethanol increased dopamine-activated current amplitude by only ϳ100, 80, and 15% at EC 35 , EC 65 , and EC 100 of dopamine in the mutant receptor, respectively. R246A Mutation Converts Trichloroethanol to a Partial Agonist. Trichloroethanol at 10 mM in the absence of agonist barely activated detectable current in the wild-type receptor. However, 10 mM trichloroethanol alone was able to activate the mutant receptor (Fig. 4A) . The maximal response activated by trichloroethanol was less than 1% of the response activated by 30 M 5-HT in the wild-type receptor. In contrast, trichloroethanol activated the mutant receptor at concentrations Ն1 mM in a concentration-dependent manner (Fig. 4B) . The trichloroethanol EC 50 and Hill coefficient values were 4.2 Ϯ 0.44 and 3.5 Ϯ 0.33 mM, respectively, in the mutant receptor. In addition, the R246A mutation significantly increased the maximal response activated by trichloroethanol to ϳ10% of the response activated by 30 M 5-HT.
Pharmacological and Biophysical Properties of Trichloroethanol Currents. As shown in Fig. 5A , the current activated by trichloroethanol in the mutant receptor was completely blocked by 300 nM tropanyl 3,5-dichlorobenzoate (MDL 72222), a competitive 5-HT 3 receptor antagonist (Fozard, 1984) . Figure 5B shows a voltage ramp from Ϫ80 to ϩ60 mV at the peak of current activated by 3 M 5-HT in the wild-type and mutant receptors and by 10 mM trichloroethanol in the mutant receptor. The shape of the current-voltage relationship was similar for both trichloroethanol and 5-HT; and the current reversed at 1.6 Ϯ 0.5 mV for trichloroethanol in the mutant receptor, at 1.8 Ϯ 0.4 mV for 5-HT in the mutant receptor, and at 1.5 Ϯ 0.4 mV for 5-HT in the wildtype receptor (analysis of variance; p ϭ 0.8), respectively. (Fig. 6A ). There was a delayed rebound current after termination of 5-HT application, which accounted for an increase in response by 8.9 Ϯ 1.7%. Preincubation with 10 mM trichloroethanol activated current that was 11.5 Ϯ 1.5% of 30 M 5-HT-activated response in the mutant receptor, and this current gradually decayed back to the baseline during the 20-s preincubation. Application of 30 M 5-HT immediately after trichloroethanol preincubation failed to activate a detectable current in the mutant receptor (Fig. 6B) .
Kinetics of Trichloroethanol-Activated Current in the R246A Receptor. We also examined the kinetics of trichloroethanol-activated current in the mutant receptor. Figure 7A depicts representative traces of 10 mM trichloroethanol-activated current in the R246A receptor. The onset and offset of the current seem to be fast, and both could be fitted with a monoexponential function. Trichloroethanolactivated current decayed exponentially in the continuous presence of trichloroethanol after reaching peak. Desensitization time course was best fitted by a monoexponential function. The average time constants for activation, deactivation and desensitization are ϳ140, 200, and 3400 ms, respectively (Fig. 7B) .
Discussion
Dopamine can function as a partial agonist at the 5-HT 3 receptor (van Hooft and Vijverberg, 1996; Hu and Lovinger, 2005) . The R246A mutation dramatically increased the potency and relative efficacy of dopamine. This observation confirms the notion that the R246 residue plays an important role in channel gating of the 5-HT 3A receptor (Hu et al., 2003) . Trichloroethanol, an allosteric modulator at the 5-HT 3 receptor (Lovinger and Zhou, 1993; Lovinger et al., 2000; Hu et al., 2006) , barely activated the wild-type 5-HT 3A receptor; however, it was converted into an agonist by the R246A mutation. The direct activation of the R246A receptor by trichloroethanol provides further evidence to support a role of the R246 residue in channel gating.
A cluster of positively charged residues is present in the preTM1 region of the Cys-loop ligand-gated ion channels. It has been demonstrated that there is an electrostatic interaction between K215 in the preTM1 and D146 in the loop 7 of the ␤2 GABA A receptor subunit (Kash et al., 2004) and between R209 in the preTM1 and E45 in loop 2 of the ␣ nicotinic acetylcholine receptor subunit (Lee and Sine, 2005) , implicating that charge interactions play a potential role in coupling agonist binding to channel gating. A previous study also implies that the R246 residue of the 5-HT 3A receptor could participate in forming salt bridges (Zhang et al., 2002) . However, it has also been argued that the overall, rather than specific, charge interactions at the gating interfaces govern the coupling mechanism (Xiu et al., 2005) . It is possible that the participation of the R246 residue in electrostatic interactions may stabilize the 5-HT 3A receptor in the closed state, and that the R246A mutation disrupts this interaction leading to facilitated transduction and channel activation. The increased relative efficacy for dopamine and trichloroethanol could well be explained by this action. The possibility of a reduction in repulsion of the charged dopamine molecule leading to an enhanced efficacy cannot be excluded, because dopamine mainly exists as cationic form at pH 7.4 (Barlow, 1976) .
It is interesting to note that the R246A mutation dramatically increased the agonism of trichloroethanol. Direct activation by ethanol has been observed in some R246 mutant 5-HT 3A (Zhang et al., 2002) and ␣2(T262W) GABA A (Ueno et al., 2000) receptors expressed in Xenopus oocytes. Observations such as similar reversal potentials for trichloroethanol and 5-HT currents, blockade of trichloroethanol current by the competitive 5-HT 3 receptor antagonist MDL 72222, and abolition 5-HT current by desensitizing the receptor with trichloroethanol suggest that trichloroethanol directly activates the R246A receptor. The activation kinetics of trichloroethanol current in the mutant receptor is much slower, whereas the deactivation kinetics of trichloroethanol current in the mutant receptor is much faster than that of 5-HT current in both the wild-type and mutant receptors (Hu et al., 2003) . However, the deactivation kinetics of trichloroethanol current is similar to that of the low-affinity agonist dopamine current in the wild-type receptor (Hu and Lovinger, 2005) . In addition, the desensitization of the trichloroethanol current is similar to that of 5-HT current in the wild-type receptor (Hu et al., 2003) . Therefore, trichloroethanol seems to bind to the R246A receptor with low affinity to activate the receptor. The exact location of the trichloroethanol binding sites for direct activation is not clear. Those sites may overlap with the agonist/competitive antagonist sites on the receptor. Alternatively, trichloroethanol could function as an allosteric agonist by binding to an allosteric site(s).
Under a saturating concentration of agonist, the response is largely determined by the interplay between agonistbound closed and open states of the receptor (Colquhoun, 1998) . We showed that trichloroethanol and ethanol enhanced the response activated by a saturating concentration of dopamine in the wild-type receptor, which is consistent with previous observations in NCB-20 cells (Lovinger et al., . Those results suggest that gating efficacy of the 5-HT 3A receptor is enhanced by both trichloroethanol and ethanol. Either an increase in open time or a decrease in closed time or both could contribute to the increase in gating efficacy. The decreased desensitization may be secondary, at least in part, to the prolonged stay of the receptor in the open state. Because the enhancement by trichloroethanol and ethanol was more obvious at lower concentrations of dopamine, the possibility that trichloroethanol and ethanol increase the affinity of dopamine also cannot be ruled out.
It is interesting to note that the R246A mutation considerably reduced the allosteric modulation of the 5-HT 3A receptor by trichloroethanol and ethanol, suggesting that the R246 residue plays a role in the actions of alcohol at the 5-HT 3A receptor. It has been suggested that the S267 residue of the ␣1 glycine receptor subunit and S270 residue of the ␣ GABA A receptor subunits participate in forming the binding pocket for alcohol and anesthetics (Mascia et al., 2000) . We have recently demonstrated that the L293 residue, an amino acid at the equivalent position of the S267 residue in the glycine receptor and S270 residue in the GABA A receptor, of the 5-HT 3A receptor is critical for alcohol modulation (Hu et al., 2006) . However, little relationship could be established between the physicochemical properties of the substituted amino acids at this position and alcohol actions. Indeed, whether the S267 residue of the glycine receptor or S270 residue of the GABA A receptor is part of the alcohol/anesthetic binding site has been questioned (Carlson et al., 2000; Chang et al., 2003) . It has been established that the S270 residue in the GABA A receptor (Scheller and Forman, 2002) and R246 and L293 residues in the 5-HT 3A receptor (Hu et al., 2003 (Hu et al., , 2006 are critical residues for channel gating. Those residues may be part of the common transducing elements for both agonists and allosteric modulators such as ethanol and trichloroethanol, so that the increase in gating efficacy due to mutations diminishes additional enhancement provided by alcohol binding. Therefore, the abolition of alcohol modulation with mutations at these residues could be secondary to the alteration in the gating process. Similar results have been observed in the GABA A receptor. Mutagenesis studies have implicated several structural elements for allosteric modulation, such as preTM1, TM2, and TM2-TM3 loop of the ␥2 subunit for benzodiazepines and anesthetics actions at the GABA A receptor. It is interesting to note that the residues at those locations are also critical for channel gating. Therefore, those elements have been defined as transducing sites for the allosteric modulators (Boileau and Czajkowski, 1999; Carlson et al., 2000; Chang et al., 2003) .
A single binding site for etomidate has been proposed for its allosteric modulation and direct activation at the GABA A receptor (Rü sch et al., 2004) . However, several studies demonstrated that the positive modulation and direct activation of the GABA A receptor by propofol and pentobarbital are mediated by binding to different sites (Krasowski et al., Dalziel et al., 1999; Chang et al., 2003) . Our data have demonstrated that trichloroethanol has multiple actions on the function of the 5-HT 3A receptor. The R246A mutation ablated the potentiation of 5-HT 3A receptor-mediated current and markedly enhanced the agonism of trichloroethanol, indicating that potentiation and direct activation by trichloroethanol seem to be distinct processes, and they probably involve at least two discrete binding sites.
In conclusion, we have confirmed that the R246 residue in the preTM1 region of the 5-HT 3A receptor is a critical site for coupling agonist binding to channel gating. In addition, our study reveals that the R246 residue is crucial for allosteric modulation by alcohols. Our findings are consistent with the idea that residues located at the membrane interface are the transducing sites for both agonist and allosteric modulators. 
